Concepedia

Author

Hisashi Tanaka

Hirosaki UniversityORCID

Also Known As

H Tanaka, H. TANAKA, H. Tanaka, Hisashi TANAKA, Hisashi Tanaka, Jun Sakakibara-Konishi, Yoshio Araki, Youtarou Takeuchi

166

Publications

1.1K

Citations

19

H-Index

34

Concepts

All Affiliations

Hirosaki UniversitySendai Kousei HospitalNational Hospital OrganizationHokkaido hospitalNTT Medical Center
HT

About

Hisashi Tanaka is an author at Hirosaki University specializing in medicine, lung cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

215

2

Pathology

8

8

166

3

Health Sciences

3

3

70

4

Immunology

3

3

47

5

Neurology

1

1

23

Hisashi Tanaka

×

31

Publications

724

Citations

17

H-Index

YearCitations

Health status and lifestyle factors as predictors of depression in middle-aged and elderly Japanese adults: a seven-year follow-up of the Komo-Ise cohort study

Hisashi Tanaka, Yosiaki Sasazawa, Shosuke Suzuki,

BMC Psychiatry

2011

103

A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol

Satoru Miura, Tateaki Naito, Shuichi Mitsunaga,

BMC Cancer

2019

55

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)

Hajime Asahina, Satoshi Oizumi, Kei Takamura,

Lung Cancer

2019

47

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALKfusion gene

Hisashi Tanaka, Akihito Hayashi, Takeshi Morimoto,

BMC Cancer

2012

42

Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study

Ryo Ko, Takehito Shukuya, Yusuke Okuma,

The Oncologist

2018

29

Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer

Hisashi Tanaka, Kageaki Taima, Masamichi Itoga,

Medical Oncology

2019

27

Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203

Yoko Tsukita, Akira Inoue, Shunichi Sugawara,

Lung Cancer

2019

26

First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002)

Gaku Yamamoto, Hajime Asahina, Osamu Honjo,

Scientific Reports

2021

24

Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility

Daichi Fujimoto, Takeshi Morimoto, Motohiro Tamiya,

JAMA Network Open

2023

24

The Influence of Age on the Outcomes of Traumatic Brain Injury: Findings from a Japanese Nationwide Survey (J-ASPECT Study-Traumatic Brain Injury)

Keitaro Yamagami, Ryota Kurogi, Ai Kurogi,

World Neurosurgery

2019

23

Page 1